| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |